Global Burden of Liver Cancer Attributable to Drug Use in Elderly Patients, 1990-2021

204 countries and territories are covered in this analysis of liver cancer incidence, mortality, and disability-adjusted life years (DALYs) attributable to drug use in patients aged 55 and older. The data, sourced from the Global Burden of Disease Study 2021, was analyzed by Chengchi Xia and published in 2026. It reveals a global increase in absolute deaths and distinct regional disparities driven by socioeconomic factors.

Use Cases

• Modeling spatiotemporal trends in liver cancer burden based on incidence and mortality data from 1990 to 2021.
• Analyzing regional disparities in disease burden based on associations with the Socio-demographic Index (SDI).
• Estimating population attributable fractions for drug-induced liver cancer based on the Comparative Risk Assessment framework.
• Identifying demographic risk patterns based on the stark male predominance and high burden in the 55-74 age group.

Strengths

• Data spans 32 years (1990-2021), enabling longitudinal trend analysis.
• Coverage includes 204 countries and territories, providing a global perspective.
• Analysis includes multiple metrics: incidence, mortality, and disability-adjusted life years (DALYs).

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The primary data file is a 218.9 KB DOCX document, which is a very small size and may contain only summary tables rather than the underlying raw data.

Provenance

Source

Global Burden of Disease (GBD) Study 2021.

Collection Method

Analysis using the Comparative Risk Assessment framework and Population Attributable Fraction calculations.

Time Range

1990 to 2021.

Freshness

Last updated 2026-03-17 13:05:56; freshness should be verified.

Geography

204 countries and territories globally.